Inhaled anticholinergics: increased risk of major adverse CV events?
- 7 Downloads
KeywordsChronic Obstructive Pulmonary Disease Tiotropium Ipratropium Ipratropium Bromide Nonfatal Stroke
- 1.Singh S, Loke YK, Furberg CD.Inhaled anticholinergics and risk of major adverse cardiovascular events in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis. JAMA: the Journal of the American Medical Association 300: 1439-1450, No. 12, 24 Sep 2008Google Scholar
- 2.Boehringer Ingelheim.Established Safety Profile of SPIRIVA(R) Confirmed by 30 Rigorously Controlled Clinical Trials. Media Release: 23 Sep 2008. Available from: URL: http://www.boehringer-ingelheim.com
© Adis International limited or Adis Data Information BV 2008